KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Petmed Express (PETS) Acquisitions (2023)

Petmed Express has reported Acquisitions over the past 1 years, most recently at $35.9 million for Q2 2023.

For Q2 2023, Acquisitions changed N/A year-over-year to $35.9 million; the TTM value through Mar 2024 reached $35.9 million, changed N/A, while the annual FY2024 figure was $35.9 million, N/A changed from the prior year.
Acquisitions for Q2 2023 was $35.9 million at Petmed Express.
Over five years, Acquisitions peaked at $35.9 million in Q2 2023 and troughed at $35.9 million in Q2 2023.